Two Oxford Health Biomedical Research Centre (BRC) Professors have received funding awards from NIHR’s Invention for Innovation (i4i) Programme The NIHR i4i Programme is a translational research funding scheme aimed at…
Clarivate, a global leader in transformative intelligence, has announced its 2024 Highly Cited Researchers. These individuals have shown significant impact in their research fields with multiple papers ranked in the…
Birmingham Biomedical Research Centre (BBRC) and Birmingham Clinical Research Facility (BCRF) played host to the first Biomedical Research Centre (BRC) and Clinical Research Facility (CRF) Inclusion Conference at “The Exchange”…
Recently, the NIHR Oxford Health Clinical Research Facility (OH CRF) has begun researching a new potential drug treatment for Treatment-Resistant Depression (TRD). A significant number of people with depression are not…
We would like to congratulate our esteemed colleague Professor Rachel Upthegrove MBE, MBBS, FRCPsych, PhD on her recent achievement of receiving the Member of the Order of the British Empire…
The Oxford Health Clinical Research Facility (OH CRF) web presence has been redeveloped and relaunched as a separate website to better reflect the important work carried out. The OH CRF…
The New Therapeutic Approaches in Translational Mental Health Conference was held on 16 September 2024 at the Mathematical Institute in Oxford. The event was organised by Betina Nair and Dr…
NIHR Oxford Health Biomedical Research Centre (OH BRC) and NIHR Oxford Biomedical Research Centre are seeking committed individuals to join their Diversity in Research Group to share experiences and ideas…
Researchers from our BRC Data Science Theme have contributed to an article on the use of Electronic Health Records (EHRs) to facilitate personalised treatments for psychiatric conditions. Clinical prediction models…
This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…
Oxford will host the first conference of its kind into body-focused repetitive behaviours (BFRBs) such as hair pulling and skin picking next month. It comes just over a year after…
A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…
The largest ever trial to investigate whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants. The first patients are being screened to see if…
In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…
Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….
Oxford University announces four new online therapies for anxiety and PTSD, now available on the NHS. The therapies target childhood anxiety and post-traumatic stress disorders and were developed with support form…
The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….
University of Oxford and OH BRC supported researchers are recruiting participants for the Oxford Semaglutide and Cognition (OxSENSE) Study. The study is investigating the effects of a single-dose of semaglutide…
Academia Meets Industry – Grand Challenges and New Horizons 16th September 2024, Mathematical Institute, Oxford The New Therapeutic Approaches in Translational Mental Health conference will bring together industry, academic and…
